Meriem MarrakchiFamily medicine intern in Tunisia, Tunisia
Title: Female sexual dysfunction in diabetics: Glycemic control and lipidic profile
Female sexual dysfunction (FSD) has been reported in women with type 2 diabetes mellitus (T2DM). Several clinical, biological and psychological factors are thought to be involved. The aim of this study was to identify the glycemic and lipid factors associated with FSD in women with T2DM.
Materials and methods
A cross-sectional and descriptive study was conducted involving a group of 30 women with T2DM. Sexual function was assessed using the Female Sexual Function Index (FSFI) questionnaire, with a score of less than 26.55 indicating FSD. We collected the patients' clinical informations and their most recent metabolic assessments.
The mean age of patients was 42.97 ± 6.66 years. FSD was detected in 53% of the women. The glycated hemoglobin of patients with FSD was 9.8% ± 1.41, against 9.5% ± 1.92 for patients without FSD (p = 0.17). The glycemic control was achieved in 6.25% and 18.75% of patients with and without FSD respectively. Low FSFI scores were correlated with high levels of triglycerides (p = 0.03) and low levels of HDL cholesterol (p = 0.035). No correlation was observed between FSFI score on one hand, and fasting glycemia (p = 0.89) or cholesterol levels (p = 0.095) on the other hand.
In this study, only hypertriglyceridemia and hypo-HDL-emia were associated with FSD. Optimal metabolic control could improve sexual function in women with T2DM.
Meriem Marrakchi completed her medical studies in 2018 at the age of 25, and she is currently in my 3rd year of residency in family medicine in Tunisia. Passionate for scientific research with over fifteen publications, She have attended and presented my works at several national and international conferences. She have a diploma in geriatrics from the Middle East Academy for Medicine of Ageing, and will be making this her future specialty.